Trailing-twelve-month (TTM) revenue is $30.18 Million with a year-over-year growth of +10.03%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $7,367,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $7,951,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-23 |
| Q1 FY2026Period ended 2026-03-31 | $6,687,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $8,171,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $30,176,000 |
Current P/S: $16,638,750 market capitalization ÷ $30,176,000 TTM revenue = 0.55x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:20:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $8.17M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:21:01.773Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Consumable Revenue | $3M | $6M | $7M | $11M | $13M | $14M |
| Instrument Revenue | $3M | $6M | $9M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | N/A | $14M | $18M | $14M | $12M |
| Asia Pacific | $850,931 | $3M | $5M |
$30.18M
$30.18 Million
+10.03%
vs. $27.43M a year ago (TTM)
+17.97%
5 Year compound annual growth rate
1 Year
+10.03%
3 Year
(1.43%)
5 Year
+17.97%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $28.51M | ($2.27M) | (7.37%) |
| 2024 | $30.78M | ($5.34M) | (14.79%) |
| 2023 | $36.12M | +$8.31M | +29.90% |
| 2022 | $27.80M | +$9.82M | +54.62% |
| 2021 | $17.98M | +$9.48M | +111.47% |
| 2020 |
TTM Growth
+10.03%
3-Year CAGR
(1.43%)
5-Year CAGR
+17.97%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:21:01.773Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $8M |
| $6M |
| Product | $6M | $12M | $20M | $27M | $27M | $27M |
|---|
| Product and Service, Other | $2M | $600,000 | $700,000 | $9M | $4M | $2M |
|---|
| Software Revenue | N/A | N/A | $5M | $6M | $6M | $6M |
|---|
| $3M |
| $2M |
| EMEA | $3M | $6M | $9M | $13M | $14M | $14M |
|---|
| North America | $4M | $9M | N/A | N/A | N/A | N/A |
|---|
| $8.50M |
| ($1.63M) |
| (16.06%) |
| 2019 | $10.13M | ($1.87M) | (15.59%) |
| 2018 | $12.00M | +$2.50M | +26.26% |
| 2017 | $9.51M | +$2.71M | +39.93% |
